FDA Approved: ROZLYTREK — Original Application (Genentech, Inc.)

View source ↗

Summary

The FDA granted approval of Rozlytrek (entrectinib) in an original NDA for adult and pediatric patients with solid tumors that harbor NTRK gene fusions, and for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Ntrk Gene Fusion Solid Tumors

Drugs mentioned

• Rozlytrek (entrectinib)

Snippet

ORIG AP for ROZLYTREK (ENTRECTINIB)